chorionic gonadotropin (A.P.L.)
chorionic gonadotropin is an FDA-licensed reference biologic from Ferring Pharmaceuticals Inc.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
1974
Reference approved
Reference product
A.P.L. chorionic gonadotropin
Ferring Pharmaceuticals Inc.
- Approved
- Dec 13, 1974
- Marketing
- Disc
- Center
- CDER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for chorionic gonadotropin, in chronological order.
Reference approval
Approval date of the reference chorionic gonadotropin product.
52 yr 3 mo ago
Frequently asked questions
Are there biosimilars approved for chorionic gonadotropin (A.P.L.)?
No 351(k) biosimilars or interchangeable biosimilars referencing chorionic gonadotropin are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.